Related Experiment Videos

MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1

A Bellacosa1, L Cicchillitti, F Schepis

  • 1Divisions of Population Science, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA. A_Bellacosa@fccc.edu

Insights

Researchers identified MED1 as a novel human DNA repair protein involved in DNA mismatch repair (MMR). MED1 interacts with MLH1 and may be a eukaryotic homologue of the bacterial MutH protein, suggesting a role for cytosine methylation in DNA repair.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • The DNA mismatch repair (MMR) system is crucial for maintaining genomic integrity and is conserved across evolution.
  • Identifying novel components of the human MMR pathway is essential for understanding genome stability.

Purpose of the Study:

  • To discover new human genes involved in DNA mismatch repair (MMR).
  • To characterize the function and interactions of newly identified MMR-associated proteins.

Main Methods:

  • Utilized the yeast interaction trap assay with the MMR protein MLH1 as bait.
  • Cloned and analyzed the function of the identified gene, MED1.
  • Investigated MED1's protein complex formation, DNA binding properties, and enzymatic activity.

Main Results:

  • Identified MED1 as a novel human protein interacting with MLH1.
  • MED1 forms a complex with MLH1, binds to methyl-CpG DNA, and exhibits endonuclease activity.
  • A MED1 mutant lacking its methyl-CpG-binding domain (MBD) resulted in microsatellite instability (MSI).

Conclusions:

  • MED1 is a novel human DNA repair protein potentially involved in MMR.
  • MED1 may be the eukaryotic homologue of the bacterial MMR endonuclease MutH.
  • Cytosine methylation might play a role in human DNA repair processes.

Related Concept Videos